-Bavarian Nordic raises capital to DKK260.9m through share issue.
NORDIC BUSINESS REPORT-December 2, 2011--Bavarian Nordic raises capital to DKK260.9m through share issue(C)2011 M2 COMMUNICATIONS http://www.m2.com
1 December 2011 - Danish biotech company Bavarian Nordic A/S (CPH:BAVA) announced Thursday that the nominal value of its share capital has grown to DKK260.9m after the share issue from mid-November.
Bavarian Nordic has 26,094,361 shares with a par value of DKK10 and they correspond to the same number of voting rights.
The company issued 213,716 new shares in the middle of November as a milestone payment for CEO Reiner Laus and two ex employees, formerly also owners, in the unit BN ImmunoTherapeutics Inc.
(EUR1 = DKK7.7)
((Comments on this story may be sent to firstname.lastname@example.org))
|Printer friendly Cite/link Email Feedback|
|Publication:||Nordic Business Report|
|Date:||Dec 2, 2011|
|Previous Article:||-Finnish Komas to acquire Cargotec's Estonian components plant.|
|Next Article:||-Chilean Ultragas to squeeze out U-Sea Bulk Shipping's minority stockholders.|